Brief Reflections on Treatment Satisfaction

Lenderking, William R.

doi:10.1111/j.1524-4733.2005.00068.x

Cited by 17 publications

(14 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, knowledge of the degree of satisfaction with treatment may make it easier to predict treatment compliance and help clinicians take health-related decisions. Therefore, this parameter may be a useful indicator to measure in daily practice and biomedical research [12]. …”

Section: Introductionmentioning

confidence: 99%

Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)

Rejas

Ruiz

Pardo

et al. 2011

BMC Med Res Methodol

View full text Add to dashboard Cite

BackgroundA previous study has documented the reliability and validity of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q) in exploring patient satisfaction with medicines for chronic health conditions in routine medical practice, but the minimally important difference (MID) of this tool is as yet unknown. The objective of this research was to estimate the MID for the SATMED-Q total score and six constituent domains.MethodsThe sample of patients (456 subjects, mean age 59 years, 53% male) used for testing psychometric properties was also used to assess MID. Item #14 of the Treatment Satisfaction Questionnaire for Medication (TSQM) was used as an anchor reference since it directly explores satisfaction with medicine on a 7-point ordinal scale (from extremely satisfied to extremely dissatisfied, with a neutral category). Patients were classified into four categories according to responses to this item (extremely satisfied/dissatisfied, very satisfied/dissatisfied, satisfied/dissatisfied, neither satisfied nor dissatisfied (neutral), and calculations were made for the total score and each domain of the SATMED-Q using standardised scores. The mean absolute differences in total score (and domains) between the neutral category and the satisfied/dissatisfied category were considered to be the MID. Effect sizes (ES) were also computed.ResultsThe MID for the total score was 13.4 (ES = 0.91), while the domain values ranged from 10.3 (medical care domain, ES = 0.43) to 20.6 (impact on daily living, ES = 0.85). Mean differences in satisfaction (as measured by the total SATMED-Q score and domain scores) using the levels of satisfaction established by item #14 were significantly different, with F values ranging from 12.2 to 88.8 (p < 0.001 in all cases).ConclusionThe SATMED-Q was demonstrated to be responsive to different levels of patient satisfaction with therapy in chronically ill subjects. The MID obtained was 13.4 points for the overall normalised scoring scale, and between 10.3 and 20.6 points for domains.

show abstract

Section: Introductionmentioning

confidence: 99%

Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)

Rejas

Ruiz

Pardo

et al. 2011

BMC Med Res Methodol

View full text Add to dashboard Cite

show abstract

“…In addition, knowledge of the degree of satisfaction with treatment can contribute to predict treatment compliance and help clinicians take decisions. Consequently, measurement of this parameter is one of the health outcomes which must be complied with in both daily clinical practice and in biomedical research [12]. Until relatively recently, most instruments designed to measure patient satisfaction with medical treatment were specific to a given disease or clinical situation.…”

Section: Introductionmentioning

confidence: 99%

Development and Validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED-Q)©

et al. 2008

View full text Add to dashboard Cite

show abstract

“…, Shikiar & Rentz , Chen et al . , Lenderking ). We speculate that the factorial validity is also linked to the nature of chronic diseases, culture and how the TSQM (version 1.4) is employed in the research or clinical setting.…”

Section: Discussionmentioning

confidence: 99%

“…Convenience, side effects, price, symptom relief, efficacy, tolerability and ease of medication use are associated with patient satisfaction and with medication treatment (Atkinson et al . , Shikiar & Rentz , Lenderking ). In patients with hypertension, satisfaction with medication is closely associated with side effects, cost and medication efficacy (Chen et al .…”

Section: Treatment Satisfaction Questionnaire For Medication (Versionmentioning

confidence: 99%

“…Treatment Satisfaction Questionnaire for Medication (version 1.4) Atkinson et al (2004) created the TSQM version 1.4 based on a model of patient satisfaction with treatment that connects health-related decisions with the desire to participate in treatment-related decisions, the perception of previous and actual health status, preferences, previous experiences and beliefs or prejudice about the efficacy and/or treatment risk. Convenience, side effects, price, symptom relief, efficacy, tolerability and ease of medication use are associated with patient satisfaction and with medication treatment (Atkinson et al 2004, Shikiar & Rentz 2004, Lenderking 2005. In patients with hypertension, satisfaction with medication is closely associated with side effects, cost and medication efficacy (Chen et al 2005).…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Reliability and validity of the Treatment Satisfaction Questionnaire for Medication among Portuguese‐speaking Brazilian patients with hypertension

Liberato

Rodrigues

Kim

et al. 2016

Journal of Clinical Nursing

View full text Add to dashboard Cite

show abstract

Brief Reflections on Treatment Satisfaction

Cited by 17 publications

References 8 publications

Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)

Minimally important difference of the Treatment Satisfaction with Medicines Questionnaire (SATMED-Q)

Development and Validation of the “Treatment Satisfaction with Medicines Questionnaire” (SATMED-Q)©

Reliability and validity of the Treatment Satisfaction Questionnaire for Medication among Portuguese‐speaking Brazilian patients with hypertension

Contact Info

Product

Resources

About